DECREASE IN BRAIN NE TURNOVER AFTER CHRONIC DMI TREATMENT - NO EFFECT WITH IPRINDOLE

被引:50
作者
ROSLOFF, BN
DAVIS, JM
机构
[1] UNIV CHICAGO,DEPT PSYCHIAT,CHICAGO,IL 60637
[2] VANDERBILT UNIV,SCH MED,DEPT PHARMACOL,NASHVILLE,TN 37203
[3] ILLINOIS STATE PSYCHIAT INST,CHICAGO,IL 60612
[4] TENNESSEE NEUROPSYCHIAT INST,NASHVILLE,TN
关键词
Brain NE turnover; Chronic administration; Desmethylimipramine; Iprindole; Tricyclic antidepressants;
D O I
10.1007/BF00432858
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Previous studies have suggested that chronic treatment with tricyclic antidepressants alters brain NE turnover. This action is more likely a biochemical correlate of their clinical effect than is the blockade of amine reuptake, because the latter occurs with acute administration, whereas tricyclics must be given chronically for clinical improvement. In this paper the effects of chronic treatment with the tricyclics desmethylimipramine (DMI) and iprindole (a clinically effective tricyclic that does not potently block amine reuptake) on rat brain NE turnover, as measured by the Conversion Index, was studied. Chronic DMI, but not iprindole, decreased NE turnover. These results are discussed regarding the proposed mechanism of action of tricyclics and the 'catecholamine hypothesis of affective disorders'. Chronic DMI also tended to decrease endogenous brain NE, and chronic treatment with either DMI or iprindole tended to decrease brain and plasma tyrosine. © 1978 Springer-Verlag.
引用
收藏
页码:335 / 341
页数:7
相关论文
共 62 条
[1]  
Aghajanian G.K., Bunney B.S., Kuhar M.J., Use of single unit recording in correlating transmitter turnover with impulse flow in monoamine neurons, New concepts in neurotransmitter regulation, pp. 115-134, (1973)
[2]  
Alpers H.S., Himwich H.E., The effects of chronic imipramine administration on rat brain levels of serotonin, 5-hydroxy-indoleacetic acid, norepinephrine and dopamine, J. Pharmacol. Exp. Ther., 180, pp. 531-538, (1972)
[3]  
Bunney W.E., Davis J.M., Norepinephrine in depressive reactions, Arch. Gen. Psychiatry, 13, pp. 438-494, (1965)
[4]  
Carlsson A., Davis J.N., Kehr W., Lindqvist M., Atack C.V., Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in vivo using an inhibitor of the aromatic amino acid decarboxylase, Naunyn-Schmiedebergs Arch. Pharmacol., 275, pp. 153-168, (1972)
[5]  
Carlsson A., Fuxe K., Hamberger B., Lindqvist M., Biochemical and histochemical studies of the effects of imipramine-like drugs and (+)amphetamine on central and peripheral catecholamine neurons, Acta Physiol. Scand., 67, pp. 481-497, (1966)
[6]  
Chang C.C., A sensitive method for spectrophotofluorometric assay of catecholamines, Int. J. Neuropharmacol., 3, pp. 643-649, (1964)
[7]  
Costa E., Simple neuronal models to estimate turnover rate of noradrenergic transmitters in vivo, Biochemistry of simple neuronal models, pp. 169-204, (1970)
[8]  
Costa E., Methods for measuring indolealkylamine and catecholamine turnover rate “in vivo”, Adv. Exp. Med. Biol., 13, pp. 157-174, (1971)
[9]  
Costa E., Neff N.H., Principle of steady-state kinetics as applied to the evaluation of drug effects on adrenergic neurons, Importance of fundamental principles in drug evaluation, pp. 185-202, (1968)
[10]  
Costa E., Neff N.H., Estimation of turnover rates to study the metabolic regulation of the steady-state level of neuronal monoamines, Handbook of neurochemistry, vol. IV, pp. 45-90, (1970)